Overview and Scope
Large molecule bioanalytical technologies are analytical methods employed in the examination and assessment of complex biological entities such as proteins and nucleic acids. These technologies are essential for comprehending the structure, functionality, and interactions of molecules, serving as pivotal tools in drug discovery, clinical diagnostics, and biotechnology research.
Sizing and Forecast
The large molecule bioanalytical technologies market size has grown rapidly in recent years. It will grow from $8.9 billion in 2023 to $10.19 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increased investment in biotechnology research, growth of proteomics research, growth in high-throughput screening, increased adoption of next-generation sequencing, increased adoption of single-cell analysis.
The large molecule bioanalytical technologies market size is expected to see rapid growth in the next few years. It will grow to $17.59 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to increasing demand for biopharmaceuticals, growing investment in life sciences research, increasing demand for point-of-care testing, increasing prevalence of chronic diseases, increasing demand for biologics and biosimilars. Major trends in the forecast period include real-time analysis, adoption of quality control labs, integration of artificial intelligence, technological advancements, adoption of cloud-based solutions, adoption of digital technologies.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/large-molecule-bioanalytical-technologies-global-market-report
Segmentation & Regional Insights
The large molecule bioanalytical technologies market covered in this report is segmented –
1) By Product And Services: Products, Services
2) By Technology: Chromatography, Mass Spectrometry, Enzyme-Linked Immunosorbent Assay, Electrophoresis, Polymerase Chain Reaction, Western Blot, Flow Cytometry, Spectrometer, Other Technologies
3) By Application: Biologics, Oligonucleotide Derived Drugs And Molecules, Viral Vector, Cell And Gene Therapy, Nanoparticles And Polymers, Disease Diagnosis, Other Applications
North America was the largest region in the large molecule bioanalytical technologies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large molecule bioanalytical technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15596&type=smp
Major Driver Impacting Market Growth
The rising focus on personalized medicine is expected to propel the growth of the large molecule bioanalytical technologies market going forward. Personalized medicine refers to adapting medical treatment and healthcare decisions to each patient’s unique traits, such as genetic makeup, biomarkers, lifestyle, and environmental factors, to maximize efficacy and reduce side effects. Factors including individual variability in disease susceptibility, a shift towards value-based healthcare, and the prioritization of patient-centered care propel the rising focus on personalized medicine. Large-molecule bioanalytical technologies are used in drug development to characterize the pharmacokinetics and pharmacodynamics of large-molecule drugs, such as monoclonal antibodies or gene therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized medicines for rare disease patients, a rise from six in 2022. Therefore, the rising focus on personalized medicine drives the growth of the large molecule bioanalytical technologies market.
Key Industry Players
Major companies operating in the large molecule bioanalytical technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Charles River Laboratories International Inc., Intertek Group plc, Shimadzu Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., HORIBA Ltd., SCIEX, Bio-Techne Corporation, Hamilton Company, Promega Corporation, Verder Group, Solvias AG, Analytik Jena AG, Genedata AG, Wyatt Technology Corporation, Nanalysis Corporation, Avomeen Analytical Services, Cergentis B.V., Halo Labs Inc., Hitachi High-Technologies Corporation, Precision NanoSystems Inc.
The large molecule bioanalytical technologies market report table of contents includes:
1. Executive Summary
2. Large Molecule Bioanalytical Technologies Market Characteristics
3. Large Molecule Bioanalytical Technologies Market Trends And Strategies
4. Large Molecule Bioanalytical Technologies Market – Macro Economic Scenario
5. Global Large Molecule Bioanalytical Technologies Market Size and Growth
.
.
.
32. Global Large Molecule Bioanalytical Technologies Market Competitive Benchmarking
33. Global Large Molecule Bioanalytical Technologies Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Large Molecule Bioanalytical Technologies Market
35. Large Molecule Bioanalytical Technologies Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
